Paion AG
PAIOF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$71.34K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $71,340.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.08 |
| Beta | 4.14 |
| Outstanding Shares | 7,134,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -4.43 |
|---|---|
| PEG | -27.06 |
| Price to Sales | 0.01 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Paion AG
15,166 employees
CEO: Jay Pestrichelli
Paion AG operates as a specialized pharmaceutical entity, concentrating its efforts on creating and selling groundbreaking treatments within the realms of anesthesia, intensive care, and critical care medicine. The company places particu...